Posts Tagged ‘pharmaceutical’

« Older Entries | Newer Entries »

Shockproofing Canada: We can make masks and ventilators, but we can’t make drugs needed to treat COVID-19

Friday, April 17th, 2020

“That’s the problem with stockpiles… You end up sitting on millions of dollars in drugs and equipment. Then you have to keep replacing it. And which ones do you stockpile?” The alternative, then, would be to expand production capacities for pharmaceuticals and medical supplies at home, but that’s more complicated than it might seem… Countries such as Canada will have to each find their own balance between self-reliance and international cooperation…

Tags: , , ,
Posted in Policy Context | No Comments »

Doug Ford didn’t protect long-term-care facilities from COVID-19. Neither did the rest of us

Thursday, April 16th, 2020

We could and should hold the current government to account — for falling behind the rest of Canada on testing, for lagging on nursing-home care, for fobbing off responsibility on to public health officials. But there is enough blame to go around — for politicians past and present, public servants and the public… Our premier has put his best face forward in recent weeks, but he still has much to answer for.

Tags: , , , , , ,
Posted in Child & Family Policy Context | No Comments »

A rescue package includes expanding medicare

Wednesday, March 25th, 2020

… as we are seeing an unprecedented collective effort to protect Canadians in the acute phase of this crisis, we also have an opportunity to ensure that every person living in Canada has access to the essential medications and dental care they need, regardless of employment status, to protect them against ongoing and future instability… On dental care, Canada has one of the least accessible systems in the developed world. Only 5 per cent of all spending on dental care is publicly funded

Tags: , , , ,
Posted in Health Debates | No Comments »

A tale of two public health crises — science is being used to stem coronavirus but not opioid deaths

Saturday, March 14th, 2020

The scientific evidence derived from the evaluation of these facilities is both comprehensive and clear: they save lives. Yet despite the mountains of evidence that’s been compiled about their effectiveness, this health intervention continues to be controversial for those who don’t know, or willingly choose to ignore, the science. Not a single death has been reported in a supervised consumption site.

Tags: , , , , ,
Posted in Health Debates | No Comments »

The public lab that could have helped fight COVID-19 pandemic

Thursday, March 12th, 2020

… our willingness to go along with the privatization cult in recent decades has left us weaker and less protected than we could be. Not only do we no longer have Connaught Labs, but Canada spends $1 billion a year funding basic medical research at Canadian universities, yet relies on the private marketplace to produce, control — and profit from — the resulting medical innovations… With a surge in future global pandemics expected, it might well be time to rethink Canada’s foolhardy attachment to the notion “the private sector always does things better.”

Tags: , , , , ,
Posted in Health History | No Comments »

Sanders’ ‘Medicare for all’ plan isn’t Canadian-style. It’s much more radical

Tuesday, March 10th, 2020

Total health-care spending here in 2019 was $264.4 billion. The public share was about $184 billion. A Sanderian-style approach would thus bring about $80 billion in annual private spending — namely, private insurance and out-of-pocket spending — on to government balance sheets… Medicare for all may be a popular slogan among left-wing activists in the U.S, but it… goes far beyond the public insurance model in Canada and elsewhere…

Tags: , , , , , ,
Posted in Health Policy Context | No Comments »

Don’t Listen to Big Pharma Lobbyists: Universal Pharmacare Would Be Good for Workers and Good for Business

Thursday, March 5th, 2020

… the average Canadian employer providing drug coverage would save $750 per year per employee under universal pharmacare… a universal pharmacare plan could save Canadian businesses as much as $14 billion annually because such a plan “would eliminate much of the cost of health-care plans that business owners pay to cover employees.” … “employers, free from soaring premiums, could pay employees better or reinvest in their businesses.” … [and] save Canadians $4.2 billion in annual prescription costs.

Tags: , , , , , , , , ,
Posted in Debates | No Comments »

‘They have failed us.’ Parents of kids with rare diseases feel let down by Ford government

Thursday, February 27th, 2020

Families needing revolutionary and expensive drugs to beat the symptoms of rare diseases like cystic fibrosis say Health Minister Christine Elliott has let them down after championing improved access to medications when the PCs were in opposition just a few years ago… Elliott said she has been trying to speed the federal and provincial approval processes for the drugs and to get them covered in Ontario… In 2014, Elliott said “we have to be able to find the money” to pay for such drugs by restructuring the health-care system.

Tags: , , , , , ,
Posted in Health Delivery System | No Comments »

Should government have a say in what drugs are prescribed to patients?

Wednesday, December 18th, 2019

Canada is slow to approve new biosimilars; since 2006, Health Canada has approved only six, compared with 13 approvals by the European Medicines Agency. We also have among the highest prices in the world for both biologics and biosimilars, so more co-ordinated and aggressive price negotiations are required.

Tags: , , ,
Posted in Health Policy Context | No Comments »

CMHA Ontario provides recommendations on Bill 116

Tuesday, December 17th, 2019

The Ontario government’s proposed Mental Health and Addictions Centre of Excellence must focus on implementing core mental health and addictions services provincially, rigorous data collection and health quality improvement initiatives… CMHA Ontario… also advised that any funds recouped from opioid manufacturers through litigation would be best directed to front-line addictions care…

Tags: , , ,
Posted in Health Policy Context | No Comments »

« Older Entries | Newer Entries »